Afuco™ Anti-Human LILRB4 ADCC Therapeutic Antibody (TRX385), ADCC Enhanced
Anti-LILRB4 ADCC Enhanced Antibody (TRX385) is an ADCC enhanced antibody produced by our Afuco™ platform. TRX385 is a monoclonal antibody that recognizes ILT3, an inhibitory receptor expressed by dendritic cells and monocytes. These pre-clinical candidates may be developed for the treatment of cancer and viral diseases.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-473CL |
| Pricing | Inquiry |
| Host | Human |
| Target | LILRB4 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage |
|